Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Agnosia × Hydromorphone × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Pain, Postoperative 1 Malignant Female Reproductive System Neoplasm 1 Liver Neoplasms 1 Kidney Neoplasms 1 Duodenal Neoplasms 1 Agnosia 1

Interventions

Morphine 2 Bupivacaine 2 Anesthesia, Local 2 Analgesia, Epidural 2 engage 8200 1 Transdermal Patch 1 Touch 1 Telemedicine 1 Surgical Instruments 1 Ropivacaine 1 Radiosurgery 1 Radiofrequency Ablation 1 Psilocybin 1 Palliative Care 1 Methods 1 Ketorolac 1 Hydromorphone 1 Exercise 1 Epinephrine 1 Electroencephalography 1 Dipyrone 1 Dexmedetomidine 1 Cryosurgery 1 Clonidine 1 Capsaicin 1 Botulinum Toxins, Type A 1 Anesthesia, Spinal 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03715517 2026-02-05

SAFER-L

University of Manitoba

Phase NA Recruiting

Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡